The past, present, and future of renal xenotransplantation

Kidney International

Volumn 51, Issue 3, 1997, Pages 932-944

  Hancock, Wayne W ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CASE REPORT; FEMALE; HUMAN; KIDNEY TRANSPLANTATION; PRIORITY JOURNAL; XENOTRANSPLANTATION;

EID: 0030929325     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1038/ki.1997.132     Document Type: Article

References (59)

1. REEMTSMA K, MCCRACKEN BH, SCHLEGEL JY, PEARL MA, PEARCE CW, DEWITT CW, SMITH PE, HEWITT RL, FLINNER RL, CREECH O JR: Renal heterotransplantation in man. Ann Surg 160:384-410, 1964
2. COZZI E, WHITE DJG: The generation of transgenic pigs as potential organ donors for humans. Nature Med 1:964-966, 1995
3. PRINCETEAU M: Greffe renale. J Med Bordeaux 26:549-555, 1905
4. JABOULAY M: De reins au pli du coude par soutures arterielles et veineuses. Lyon Med 107:575-583, 1906
5. UNGER E: Nierentransplantationen. Klin Wochenschr 47:573-582, 1910
6. NEUHOF H: Transplantation of Tissues. Appleton and Co., New York, 1923, p 260
7. STARZL TE, MARCHIORO TL, PETERS GN, KIRKPATRICK CH, WILSON WEC, PORTER KA, RIFKIND D, OGDEN DA, HITCHCOCK CR, WADDELL WR: Renal heterotransplantation from baboon to man: experience with 6 cases. Transplantation 2:752-776, 1964
8. HITCHCOCK CR, KISER JC, TELANDER RL, SELJOSKOG EL: Baboon renal grafts. JAMA 189:934-937, 1964
9. KAUFMAN HM JR, DAILY OP: Xenotransplantation. The Scientist, 19 Feb 1996, p 11
10. CRAMER DV: Xenografts: The hot zone revisited. N Dev Transplant Med 2:14-15, 1995
11. CALNE RY: Organ transplantation between widely disparate species. Transplant Proc 11:550-556, 1970
12. MAKOWKA L, CRAMER DV, HOFFMAN A, SHER L, PODESTA L: Pig liver xenografts as a temporary bridge for human allografting. Xeno 1:27-29, 1993
13. GALILI U, MACHER B, BUEHLER J, SHOHET SB: Human natural anti-alpha-galactosyl IgG. II. The specific recognition of alpha (1-3) linked galactose residues. J Exp Med 162:573-582, 1985
14. GALILI U: Significance of natural human anti-Gal antibody in xenotransplantation. Xeno 2:84-87, 1994
15. MCKENZIE IFC, COHNEY S, VAUGHAN HA, OSMAN N, ATKIN J, ELLIOTT E, FODOR WL, GALLOP MA, OLDENBERG KR, BURTON D, SANDRIN MS: Overcoming the anti-Gala(1-3)Gal reaction in xenotransplantation. Xeno 3:86-88, 1995
16. TEARLE RG, TANGE MJ, ZANNETTINO ZL, KATERELOS M, SHINKEL TA, VANDENDEREN BJW, LONIE AJ, LYONS I, NOTTLE MB, COX T, BECKER C, PEURA AM, WIGLEY PL, CRAWFORD RJ, ROBINS AJ, PEARSE MJ, D'APICE AJF: The alpha-1,3-galactosyltransferase knockout mouse-implications for xenotransplantation. Transplantation 61: 13-19, 1996
17. BACH FH, ROBSON SC, FERRAN C, WINKLER H, MILLAN MT, STUHLMEIER KM, VANHOVE B, BLAKELY ML, VAN DER WERF WJ, HOFER E, DE MARTIN R, HANCOCK WW: Endothelial cell activation and thromboregulation during xenograft rejection. Immunol Rev 141:5-30, 1994
18. BACH FH, ROBSON SC, WINKLER H, FERRAN C, STUHLMEIER KM, WRIGHTON CJ, HANCOCK WW: Barriers to xenotransplantation. Nature Med 1:869-873, 1995
19. HANCOCK WW, BACH FH: The immunopathology of discordant xenograft rejection. Xeno 2:68-74, 1994
20. PLATT JP, FISCHEL RJ, MATAS AJ, REIF SA, BOLMAN RM, BACH FH: Immunopathology of hyperacute xenograft rejection in a swine-to-primate model. Transplantation 52:214-219, 1991
21. LEVENTHAL JR, JOHN R, FRYER JP, WITSON JC, DERLICH JM, REMISZEWSKI J, DALMASSO AP, MATAS AJ, BOLMAN RM: Removal of baboon and human antiporcine IgG and IgM natural antibodies by immunoadsorption - Results of in vitro and in vivo studies. Transplantation 59:294-299, 1995
22. KOBAYSHI T, NEETHLING FA, KOREN E, TANIGUCHI S, YE Y, NIEKRASZ M, TAKAGI H, HANCOCK WW, COOPER DKC: In vitro and in vivo investigation of the anti-complement agents, FUT-175 and K76COOH, in the prevention of hyperacute rejection following discordant xenotransplantation in a non-human primate model. Transplant Proc 28:604, 1996
23. ROBSON SC, CANDINAS D, SIEGAL JB, KOPP C, MILLAN M, HANCOCK WW, BACH FH: Potential mechanism of abnormal thromboregulation in xenograft rejection: Loss of ecto-ATPases upon endothelial cell activation. Transplant Proc 28:536, 1996
24. COUGHLAN AF, BERNDT MC, DUNLOP LC, HANCOCK WW: In vivo studies of P-selectin and platelet-activating factor during endotoxemia, accelerated allograft rejection, and discordant xenograft rejection. Transplant Proc 25:2930-2932, 1993
25. CANDINAS D, LESNIKOSKI BA, HANCOCK WW, OTSU I, KOYAMADA N, DALMASSO AP, ROBSON SC, BACH FH: Inhibition of platelet integrin GPIIb/IIIa prolongs survival of discordant cardiac xenografts. Transplantation 62:1-5, 1996
26. ROBSON SC, YOUNG VK, COOK NS, METTERNICH R, KASPER-KONIG W, LESNIKOSKI BA, PIERSON RN, HANCOCK WW, WHITE DJG, BACH FH: Thrombin inhibition in an ex vivo model of porcine heart xenograft hyperacute rejection. Transplantation 61:862-868, 1996
27. BLAKELY ML, VANDERWERF WJ, BERNDT MC, DALMASSO AP, BACH FH, HANCOCK WW: Activation of intragraft endothelial and mononuclear cells during discordant xenograft rejection. Transplantation 58:1059-1066, 1994
28. PLATT JL, VERCELLOTTI GM, LINDMAN BJ, OEGAMA TR, BACH FH, DALMASSO AP: Release of heparan sulphate from endothelial cells: Implications for pathogenesis of hyperacute rejection. J Exp Med 171:1363-1369, 1990
29. PLATT JL, DALMASSO AP, LINDMAN BJ, IHRCKE NS, BACH FH: The role of C5a and antibody in the release of heparan sulfate from endothelial cells. Eur J Immunol 21:2887-2892, 1991
30. HUNT BJ, ROSENBERG RD: The essential role of haemostasis in hyperacute rejection. Xeno 1:16-19, 1993
31. CANDINAS D, LESNIKOSKI BA, ROBSON SC, MIYATAKE T, SCESNEY SM, MARSH HC, RYAN US, DALMASSO AP, HANCOCK WW, BACH FH: Effect of repetitive high-dose treatment with soluble complement receptor type I and cobra venom factor on discordant xenograft survival. Transplantation 62:336-342, 1996
32. ROONEY IA, LISZEWSKI MK, ATKINSON JP: Using membrane-bound complment regulatory proteins to inhibit rejection. Xeno 1:29-35, 1993
33. DALMASSO AP, VERCELLOTTI GM, PLATT JL, BACH FH: Inhibition of complement-mediated endothelial cell cytotoxicity by decay-accelerating factor. Potential for prevention of xenograft hyperacute rejection. Transplantation 52:530-536, 1991
34. CANDINAS D, KOYAMADA N, MIYATAKE T, HECHENLEITNER P, MARK W, BACH FH, HANCOCK WW: T cell-independence of macrophage and NK cell infiltration, cytokine production and endothelial activation during delayed xenograft rejection. Transplantation 62:1920-1926, 1996
35. HANCOCK WW: Immunopathology of discordant xenograft rejection, in Xenotransplantation, edited by COOPER DKC, Berlin, Springer-Verlag, in press
36. HANCOCK WW: Chemokines and the pathogenesis of T cell-dependent immune responses. Am J Pathol 148:681-684, 1996
37. CELI A, PELLIGRINI G, LORENZET R, DEBLASI A, READY N, FURIE BC, FURIE B: P-selectin induces the expression of tissue factor on monocytes. Proc Natl Acad Sci USA 91:8767-8772, 1994
38. FRYER JP, LEVENTHAL JR, DALMASSO AP, CHEN S, SIMONE PA, GOSWITZ JJ, REINSMOEN NL, MATAS AJ: Beyond hyperacute rejection - Accelerated rejection in a discordant xenograft model by adoptive transfer of specific cell subsets. Transplantation 59:171-176, 1995
39. DUCHLEK M, OFFTERDINGER M, HOLZMULLER H, LIPP J, CHU CT, ASCHAUER B, BACH FH, HOFER E: NKG2-C is a receptor on human natural killer cells that recognizes structures on K562 target cells. Eur J Immunol 25:2923-2928, 1995
40. RUSSELL ME, UTANS U, WALLACE AF, LIANG P, ARCECI RJ, KARNOVSKY MJ, WYNER LR, YAMASHITA Y, TARN C: Identification and upregulation of galactose/N-acetylgalactosamine macrophage lectin in rat cardiac allografts with arteriosclerosis. J Clin Invest 94:722-730, 1994
41. GOODMAN DJ, VON ALBERTINI M, WILSON A, MILLAN MT, BACH FH: Direct activation of porcine endothelial cells by human NK cells. Transplantation 61:763-771, 1996
42. MALYGUINE AM, SAADI S, PLATT JL, DAWSON JR: Human natural killer cells induce morphologic changes in porcine endothelial cell monolayers. Transplantation 61:161-164, 1996
43. GREY S, TSUCHIDA A, HAU H, ORTHNER CL, SALEM HH, HANCOCK WW: Selective inhibitory effects of the anticoagulant activated protein C on the responses of human mononuclear phagocytes to LPS, IFN-γ or phorbol ester. J Immunol 153:3664-3670, 1994
44. GREY ST, HANCOCK WW: A physiologic anti-inflammatory pathway based upon thrombomodulin expression and generation of activated protein C by human mononuclear phagocytes. J Immunol 156;2256-2263, 1996
45. ILDSTAD ST: Xenotransplantation for AIDS. Lancet 347:761, 1996
46. SACHS DH, SYKES M, GREENSTEIN JL, COSIMI AB: Tolerance and xenograft survival. Nature Med 1:969, 1995
47. TEARLE RG, TANGE MJ, ZANNETTINO ZL, KATERELOS M, SHINKEL TA, VANDENDEREN BJW, LONIE AJ, LYONS I, NOTTLE MB, COX T, BECKER C, PEURA AM, WIGLEY PL, CRAWFORD RJ, ROBINS AJ, PEARSE MJ, D'APICE AJF: The alpha-1,3-galactosyltransferase knockout mouse - implications for xenotransplantation. Transplantation 61: 13-19, 1996
48. GALILI U: Interaction of the natural anti-gal antibody with alpha-galactosyl epitopes - a major obstacle for xenotransplantation in humans. Immunol Today 14:480-482, 1993
49. BACH FH, TURMAN MA, VERCELLOTTI GM, PLATT JL, DALMASSO AP: Accommodation: a working paradigm for progressing towards clinical discordant xenografting. Transplant Proc 23:205-208, 1991
50. THOMAS F, ARANEDA D, HENRETTA J, PUTMAN K, MARCHMAN W: Extended and expanded studies of xenograft rejection in immunodeficient animals. Transplant Proc 26:1224-1227, 1994
51. MARWICK C: British, American reports on xenotransplantation. JAMA 276:589-590, 1996
52. CANDINAS D, LESNIKOSKI BA, HANCOCK WW, OTSU I, KOYAMADA N, DALMASSO AP, ROBSON SC, BACH FH: Inhibition of platelet integrin GPIIb/IIIa prolongs survival of discordant cardiac xenografts. Transplantation 62:1-5, 1996
53. GALILI U: Evolution and pathophysiology of the human natural anti-alpha-galactosyl IgG (anti-gal) antibody. Springer Semin Immunopathol 15:155-171, 1993
54. BROSTJAN C, ANRATHER I, CSIZMADIA V, STROKA D, SOARES M, BACH FH, WINKLER H: Glucorticoid-mediated repression of NF kappa B activity in endothelial cells does not involve induction of I kappa B alpha synthesis. J Biol Chem 271:19612-19616, 1996
55. GOSSEN M, FREUNDLIEB S, BENDER G, MÜLLER G, HILLEN W, BUJARD H: Transcriptional activation by tetracycline in mammalian cells. Science 268:1766-1769, 1995
56. SAADI S, PLATT JL: Transient perturbation of endothelial integrity induced by natural antibodies and complement. J Ex Med 181:21-31, 1995
57. BACH FH, FERRAN C, HECHENLETTNER P, MARK W, KOYAMADA N, MIYATAKE T, WINKLER H, BADRICHANI A, CANDINAS D, HANCOCK WW: Accommodation of vascularized xenografts: Expression of "protective genes" by donor endothelial cells in a host Th2 cytokine environment. Nature Med, in press
58. FERRARESSO M, TIAN L, GHOBRIAL R, STEPKOWSKI SM, KAHAN BD: Rapamycin inhibits production of cytotoxic but not noncytotoxic antibodies and preferentially activates T helper 2 cells that mediate long-term survival of heart allografts in rats. J Immumol 153:3307-3318, 1994
59. SALTUS R: Man receives pig brain cell implant. Boston Globe, 20 April 1995, p 29